Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002 May 04; 359(9317):1541-9.

View in: PubMed

collapse authors with profiles